Infectious Disease

Latest News


CME Content


SAN DIEGO -- A vaccine created from hepatitis B surface antigen linked to an immunostimulant led to more rapid and durable immune responses and greater seroprotection in older patients compared with the conventional vaccine, according to results of a phase III trial reported here.

SAN DIEGO -- Older patients with HIV infection have robust responses to highly active antiretroviral therapy (HAART), with no increased risk of metabolic disorders or other adverse effects, according to two studies.

SAN DIEGO -- Eradication of Helicobacter pylori may have had the unintended consequence of unleashing an asthma threat even as the risk of gastric ulcer and cancer declined, results of a study reported here suggest.

ROCHESTER, N.Y. -- A combination vaccine that adds hepatitis B and polio to the standard DTP (diphtheria, tetanus, pertussis) vaccine was found safe and just as immunogenic as the customary five separate shots, according to a 22-center study.

Within the past 7 years, the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile infections has significantly increased. Risk factors for MRSA infection include previous antibiotic therapy and living arrangements such as prisons or military barracks that involve close, frequent contact with infected persons. Treat stable patients with MRSA skin infections with oral antibiotics in addition to incision and drainage; hospitalization and intravenous antibiotics are recommended for patients whose condition is unstable or who are unlikely to adhere to an oral regimen. A new strain of C difficile, BI/NAP1, has been associated with recurrent infection; more severe disease that mandates urgent colectomy; and dramatically higher mortality in vulnerable populations, such as older adults. Although oral metronidazole has been the mainstay of treatment of C difficile infection, oral vancomycin may be slightly more effective in patients with severe disease.